# Fortress Biotech (FBIO) — Earnings

FBIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/fbio/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.08 |
| EPS estimate | −$0.20 |
| EPS surprise | +60.00% |
| Revenue surprise | +2.28% |
| Revenue | $18.7M |
| Revenue estimate | $18.3M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1429260/000110465926095964/fbio-20260630x10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/c67c0aea-0c8c-70df-21ad-71d132c789b1.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$0.20 | −$0.08 | 60.00% | $18.3M | $18.7M |
| Q1 2026 | May 14, 2026 | −$0.22 | $2.82 | 1381.82% | $16.3M | $16.0M |
| Q4 2025 | Mar 31, 2026 | $0.11 | −$0.15 | -236.36% | $26.2M | $16.1M |
| Q3 2025 | Nov 14, 2025 | −$0.42 | $0.11 | 126.19% | $21.0M | $17.6M |
| Q2 2025 | Aug 14, 2025 | −$0.36 | $0.45 | 225.00% | $14.5M | $16.4M |
| Q1 2025 | May 15, 2025 | −$0.50 | −$0.48 | 3.03% | $11.6M | $13.1M |
| Q4 2024 | Mar 31, 2025 | −$0.75 | −$0.17 | 77.43% | $14.6M | $15.1M |
| Q3 2024 | Nov 14, 2024 | −$0.60 | −$0.76 | -27.73% | $32.2M | $14.6M |
| Q2 2024 | Aug 13, 2024 | −$1.22 | −$0.73 | 40.33% | $14.8M | $14.9M |
| Q1 2024 | May 15, 2024 | −$1.73 | −$1.03 | 40.46% | $14.1M | $13.0M |
| Q4 2023 | Mar 28, 2024 | −$1.65 | −$0.78 | 52.58% | $15.1M | $19.9M |
| Q3 2023 | Nov 14, 2023 | −$3.21 | −$0.94 | 70.68% | $14.5M | $34.8M |
| Q2 2023 | Aug 14, 2023 | −$3.41 | −$3.60 | -5.49% | $15.5M | $17.4M |
| Q1 2023 | May 15, 2023 | −$3.00 | −$3.15 | -5.00% | $17.3M | $12.4M |
| Q4 2022 | Mar 30, 2023 | −$3.33 | −$4.50 | -35.14% | $22.1M | $16.4M |
| Q3 2022 | Nov 14, 2022 | −$4.05 | −$3.75 | 7.41% | $20.8M | $16.5M |
| Q2 2022 | Aug 11, 2022 | −$2.81 | −$3.60 | -28.25% | $22.8M | $18.9M |
| Q1 2022 | May 12, 2022 | −$2.97 | −$2.70 | 9.09% | $20.1M | $23.9M |
| Q4 2021 | Mar 28, 2022 | $1.25 | −$5.70 | -556.00% | $39.6M | $18.3M |
| Q3 2021 | Nov 15, 2021 | −$1.23 | −$3.90 | -218.37% | $18.4M | $21.1M |

## Frequently Asked Questions

### When did Fortress Biotech (FBIO) last report earnings?

Fortress Biotech last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did FBIO beat earnings estimates?

Yes. Fortress Biotech reported EPS of −$0.08 for Q2 2026 against a −$0.20 estimate — a 60.00% beat.

### How much revenue did FBIO report last quarter?

Fortress Biotech reported $18.7M in revenue for Q2 2026, against a consensus estimate of $18.3M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).